Programmable
Blood

Blood abundance determines what medicine can do.

Research and medicine depend on a supply of human and animal blood components.

Plasma Bioworks manufactures platelets at scale without requiring new animal or human donations per batch.

Starting with platelet lysates for cell culture, we aim to expand toward regenerative medicine, transfusions, and AI-guided programmable blood.

Our ambition is to grow blood abundantly and programmable.